Subscribe
Close
  • Free for qualified executives and consultants to industry

  • Receive quarterly issues of Area Development Magazine and special market report and directory issues

Renew

McKesson Establishes Delhi Township, Michigan, Pharmaceutical Distribution Center

05/30/2021
Global healthcare supply chain company McKesson will make a significant investment in a pharmaceutical distribution center in Delhi Township, Michigan. The project is expected to create more than 80 jobs in the region.

The new 174,000 sq. ft. facility is now under construction on an approximately 23-acre parcel of industrial park land at the southeast corner of Holt Road and Holloway Drive, 25 acres of which was purchased from the Delhi Township Downtown Development Authority.

“We look forward to bringing the latest supply chain technology and the associated jobs to our new distribution center in Holt, Michigan,” shared Chris Van Norman, Vice President, Network Operations, McKesson U.S. Pharmaceutical. “We are making it easier for customers in Michigan to provide patients with life-saving medications by establishing long-term stability in the region. We believe it’s not just a package, it’s a patient, and we continue to deliver to 99.99% accuracy, on time and with care.”

The McKesson footprint into the Lansing region's growing medical technologies (medtech) industry cluster, which has doubled in employment size over the past decade, adds another critical piece to the region’s global healthcare ecosystem, LEAP officials said. The new facility is located just a few miles south along US-127 from McLaren Healthcare's $600M investment into a new hospital and Karmanos cancer center campus.

“Successfully competing to attract a global leader like McKesson is a clear sign that the Lansing region’s medtech industry is on the rise as a top value opportunity in the nation,” said Bob Trezise, president and CEO of Lansing Economic Area Partnership (LEAP). “As one of the few areas in the U.S. building a new hospital campus, with two new premier cancer centers, plus nuclear medicine treatment discoveries made possible by FRIB, the addition of McKesson is a natural fit,” he added.

Share

Exclusive Research